Fenprostalene

DB11411

small molecule vet_approved

Deskripsi

Struktur Molekul 2D

Berat 402.487
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

104 Data
Icosapent The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Icosapent.
Indomethacin The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Indomethacin.
Nabumetone The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Nabumetone.
Ketorolac The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Ketorolac.
Tenoxicam The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Tenoxicam.
Celecoxib The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Celecoxib.
Tolmetin The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Tolmetin.
Rofecoxib The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Rofecoxib.
Piroxicam The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Piroxicam.
Fenoprofen The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Fenoprofen.
Valdecoxib The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Valdecoxib.
Diclofenac The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Diclofenac.
Sulindac The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Sulindac.
Flurbiprofen The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Flurbiprofen.
Etodolac The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Etodolac.
Mefenamic acid The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Mefenamic acid.
Naproxen The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Naproxen.
Sulfasalazine The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Sulfasalazine.
Phenylbutazone The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Phenylbutazone.
Meloxicam The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Meloxicam.
Carprofen The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Carprofen.
Diflunisal The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Diflunisal.
Salicylic acid The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Salicylic acid.
Meclofenamic acid The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Meclofenamic acid.
Acetylsalicylic acid The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Acetylsalicylic acid.
Oxaprozin The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Oxaprozin.
Ketoprofen The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Ketoprofen.
Balsalazide The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Balsalazide.
Ibuprofen The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Ibuprofen.
Lumiracoxib The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Lumiracoxib.
Magnesium salicylate The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Magnesium salicylate.
Salsalate The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Salsalate.
Choline magnesium trisalicylate The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Choline magnesium trisalicylate.
Antrafenine The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Antrafenine.
Aminophenazone The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Aminophenazone.
Antipyrine The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Antipyrine.
Tiaprofenic acid The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Tiaprofenic acid.
Etoricoxib The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Etoricoxib.
Taxifolin The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Taxifolin.
Oxyphenbutazone The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Oxyphenbutazone.
Licofelone The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Licofelone.
Nimesulide The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Nimesulide.
Benoxaprofen The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Benoxaprofen.
Zomepirac The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Zomepirac.
Cimicoxib The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Cimicoxib.
Lornoxicam The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Lornoxicam.
Aceclofenac The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Aceclofenac.
Zaltoprofen The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Zaltoprofen.
Azapropazone The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Azapropazone.
Parecoxib The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Parecoxib.
Salicylamide The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Salicylamide.
Kebuzone The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Kebuzone.
Isoxicam The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Isoxicam.
Indoprofen The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Indoprofen.
Ibuproxam The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Ibuproxam.
Floctafenine The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Floctafenine.
Fenbufen The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Fenbufen.
Etofenamate The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Etofenamate.
Epirizole The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Epirizole.
Benzydamine The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Benzydamine.
Dexibuprofen The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Dexibuprofen.
Dexketoprofen The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Dexketoprofen.
Droxicam The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Droxicam.
Tolfenamic acid The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Tolfenamic acid.
Firocoxib The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Firocoxib.
Clonixin The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Clonixin.
Morniflumate The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Morniflumate.
Propacetamol The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Propacetamol.
Talniflumate The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Talniflumate.
Robenacoxib The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Robenacoxib.
Tepoxalin The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Tepoxalin.
Flunixin The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Flunixin.
Polmacoxib The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Polmacoxib.
Nitroaspirin The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Nitroaspirin.
Indobufen The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Indobufen.
Ebselen The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Ebselen.
Tinoridine The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Tinoridine.
Alclofenac The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Alclofenac.
Fentiazac The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Fentiazac.
Suxibuzone The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Suxibuzone.
Bumadizone The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Bumadizone.
Alminoprofen The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Alminoprofen.
Difenpiramide The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Difenpiramide.
Nifenazone The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Nifenazone.
Lonazolac The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Lonazolac.
Tenidap The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Tenidap.
Propyphenazone The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Propyphenazone.
Proglumetacin The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Proglumetacin.
Guacetisal The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Guacetisal.
Ethenzamide The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Ethenzamide.
Carbaspirin calcium The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Carbaspirin calcium.
Mofebutazone The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Mofebutazone.
Proquazone The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Proquazone.
Benorilate The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Benorilate.
Pirprofen The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Pirprofen.
Acemetacin The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Acemetacin.
Imidazole salicylate The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Imidazole salicylate.
SC-236 The therapeutic efficacy of Fenprostalene can be decreased when used in combination with SC-236.
NS-398 The therapeutic efficacy of Fenprostalene can be decreased when used in combination with NS-398.
Flurbiprofen axetil The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Flurbiprofen axetil.

Referensi & Sumber

Artikel (PubMed)
  • PMID: 12499683
    Hori T, Akikawa T, Kawakami E, Tsutsui T: Fenprostalene-induced abortion in bitches. J Vet Med Sci. 2002 Nov;64(11):993-8.
  • PMID: 3765302
    Boland MP, MacDonnell HF, Ahmed TS, Reid JF: Use of fenprostalene in superovulated beef heifers. Vet Rec. 1986 Sep 6;119(10):241-2.
  • PMID: 6620155
    Johnson DM, Taylor WF, Thompson GF, Pritchard RA: Degradation of fenprostalene in aqueous solution. J Pharm Sci. 1983 Aug;72(8):946-8.
  • PMID: 16726532
    Haibel GK, Hull BL: Induction of parturition in goats with fenprostalene. Theriogenology. 1988;30(5):901-3.
  • PMID: 6502492
    Johnson DM, Taylor WF: Degradation of fenprostalene in polyethylene glycol 400 solution. J Pharm Sci. 1984 Oct;73(10):1414-7.
  • PMID: 3381422
    Stephens S, Boland MP, Roche JF, Reid JF, Bourke S: Induction of parturition in swine with the prostaglandin analogue fenprostalene. Vet Rec. 1988 Mar 26;122(13):296-9.
  • PMID: 3479578
    Savage NC, Liptrap RM: Induction of ovulation in cyclic mares by administration of a synthetic prostaglandin, fenprostalene, during oestrus. J Reprod Fertil Suppl. 1987;35:239-43.
  • PMID: 6591624
    Martinez J, Thibier M: Fertility in anoestrous dairy cows following treatment with prostaglandin F2 alpha or the synthetic analogue fenprostalene. Vet Rec. 1984 Jul 21;115(3):57-9.
Menampilkan 8 dari 10 artikel.

Contoh Produk & Brand

Produk: 0 • International brands: 1
International Brands
  • Synchrocept B

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul